ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 740033 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 740033; 2) Community: the network communities that were significantly associated with the response to NSC 740033; 3) Molecule: the relationships between components within communities and NSC 740033; 4) MDR: the compounds that were significantly associated with the NSC 740033.

NSC Compound Enrichment Correlation
NSC 710716 Null 0.0385613993886001 0.31779315
NSC 710895 3-[(1H-Indol-3-ylethyl)amino]-2-(3-isopropoxyphenyl)-2H-pyrido[4,3-e]-1,2,4,-thiadiazine 1,1-dioxide 0.0385613993886001 0.22260203
NSC 714379 Null 0.0385613993886001 0.19800014
NSC 720386 Methyl-12.alpha.-acetoxy-5.beta.cholan-24-oate-3-spiro-6'-(1',2',4',5'-tetraoxacyclohexane)-3'-spirocyclohexane 0.0385613993886001 0.18191212
NSC 722854 1,4-di-N-oxide-2-phenylcarbonyl-3-trifluoromethylquinoxaline 0.0385613993886001 0.38448075
NSC 730868 (+)-(2R,3R)-6-{4-[(3-hydroxymethyl)oxiran-2-yl]buta-1,3-diyn yl}-2H-pyran-2-one 0.0385613993886001 0.33632832
NSC 735030 Null 0.0385613993886001 0.33484823
NSC 737757 2-(4-((oxiran-2-yl)methoxy)styryl)-4,5-dihydrooxazole 0.0385613993886001 0.26927505
NSC 740 Methotrexate 0.0385613993886001 0.51754652
NSC 744063 Null 0.0385613993886001 0.32027495
Total:134  Current:116    [First] [Prev] [Next] [Last]